Aequi Acquisition Corp is a blank check company incorporated in 2020 and headquartered in Greenwich, Connecticut. The company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It aims to identify and acquire a target business primarily in the healthcare industry including sectors such as biopharmaceuticals, medical devices, diagnostics, life science tools, and healthcare services, both within the United States and internationally. Aequi Acquisition Corp's business model focuses on leveraging its management team's experience in healthcare and financial markets to create long-term shareholder value by identifying businesses with growth potential.
Recent major developments include the company's announcement in July 2023 to liquidate and return capital to shareholders, following the determination by its Board of Directors that it would not be feasible to complete an initial business combination by the required deadline in August 2023. Consequently, the company plans to redeem all outstanding Class A common stock shares at an estimated redemption price of approximately $10.25 per share and intends to file to delist from Nasdaq and terminate reporting obligations. Prior to this decision, Aequi Acquisition Corp had pursued a strategic approach to acquire data-centric, growth-oriented consumer technology companies, including sectors such as retail, education, financial technology, media and gaming, healthcare and wellness, legal services, and eco-friendly packaging. The company sought targets demonstrating accelerating revenue potential or strong prospects for expansion via organic growth or acquisitions.
Overall, Aequi Acquisition Corp functions as a special purpose acquisition company (SPAC) with a focus on healthcare and consumer technology sectors, leveraging its board's deep industry networks and capital markets expertise to source potential business combinations. The company’s operational scope includes strategic sourcing from venture-backed companies, private equity sponsors, family offices, and management teams, aimed at driving transformational growth and innovation. Despite its initial objectives and focused efforts, the company is currently in the process of dissolution due to the inability to consummate a qualifying acquisition within the stipulated time frame. This liquidation marks a significant operational shift in the company’s brief history.